This review discusses the treatment of primary, nonmetastatic HER2-positive breast cancer in the adjuvant and neoadjuvant settings-settings in which tremendous progress has been made.
Ursa Brown-Glaberman, MD
Advertisement
Articles by Ursa Brown-Glaberman, MD
Advertisement
Latest Updated Articles
HER2-Targeted Therapy for Early-Stage Breast Cancer: A Comprehensive ReviewPublished: April 15th 2014 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Anti-TIGIT Combination Therapy Yields Positive Survival in Gastric Cancers
2
Debate Round 3: Timing of Treatment Initiation in LR-MDS (Earlier vs Delayed)
3
Charting the Evolution of TKIs and Finding the Next Breakthrough in CML
4
Debate Round 2: Managing Luspatercept Super Responders (Dose Reduce vs Hold Dose)
5
